Home › Study of Merck melanoma drug halted after survival prolonged
 

Keywords :   


Study of Merck melanoma drug halted after survival prolonged

2015-03-24 18:27:10| Biotech - Topix.net

Merck & Co Inc said on Tuesday a large study of its Keytruda melanoma treatment will be stopped early because an independent monitoring committee determined the drug succeeded in its goal of prolonging survival in previously untreated patients with advanced melanoma. REUTERS: Merck & Co Inc said on Tuesday a large study of its Keytruda melanoma treatment will be stopped early because an independent monitoring committee determined the drug succeeded in its goal of prolonging survival in previously untreated patients with advanced melanoma.

Tags: study drug survival prolonged

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
26.06Horizon expert 'gave evidence based on informal chats'
26.06Automotive Color by BASF Recognized with Renowned Red Dot Award
26.06Beckers Commits to Widespread Science Based Targets
26.06PPG to Announce Second-quarter 2024 Results July 18
26.06Fresh Coat for First Responders: New Hampshire Fire Station Gets a Makeover by California Paints
26.06Michigan Sets Record Recycling Rate in 2023, Recycles Nearly 70,000 Tons of Materials
26.06Companies Seek Federal EPR: How Producers Can Prepare
26.06Q&A with GFLs Tyler Stefure: Integrating New Fleet Tech & Upholding GFL Values
More »